A Phase 1b Dose Expansion Study Evaluating Safety, Preliminary Anti-Tumor Activity, and Accelerated T Cell Reconstitution with NT-I7 (Efineptakin Alfa), a Long-Acting Human IL-7, A... von Ghobadi, Armin, Budde, L. Elizabeth, Galal, Ahmed, Stermer, Kristina, Bierly, Allison, Ferrando-Martinez, Sara, Lee, Byung Ha, DiPersio, John F.

Volltext

Trial in progress: A phase 1b study evaluating the safety, tolerability, and preliminary anti-tumor activity of NT-I7 (efineptakin alfa), a long-acting human IL-7, post-tisagenlecl... von Ghobadi, Armin, Budde, L Elizabeth, Galal, Ahmed, Stermer, Kristina, Austin, TaShara Lynn, Fan, Jean, DiPersio, John F.

Volltext

CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA von Derek Li, Yuping, Luo, Jingqin Rosy, Grote, Cierra, Nehring, Leslie, Katumba, Ruth, Etter, Kelsey, Barozinsky, Kaiden, Ferrando-Martinez, Sara, Stermer, Kristina, Lee, Byung Ha, Johanns, Tanner, Butt, Omar, Huang, Jiayi, Campian, Jian L, Chheda, Milan G

Volltext

CTIM-30. NT-I7, A LONG-ACTING INTERLEUKIN-7, PROMOTES ACTIVATION, CYTOTOXIC FUNCTION, AND SELECTIVE CLONOTYPE EXPANSION OF CD8+ T CELLS IN PATIENTS WITH HIGH GRADE GLIOMAS von Barozinsky, Kaiden, Foltz, Jennifer A, Butt, Omar H, Zhou, Alice Y, Singhal, Kartik, Griffith, Obi, Griffith, Malachi, Etter, Kelsey, Grote, Cierra, Luo, Jingqin, Nehring, Leslie, Katumba, Ruth, Ferrando-Martinez, Sara, Stermer, Kristina, Lee, Byung Ha, Johanns, Tanner, Huang, Jiayi, DiPersio, John, Chheda, Milan, Fehniger, Todd, Campian, Jian L

Volltext